Summary:
Mild to moderate Alzheimer's disease or memory loss.
Qualified Participants Must:
Be 50 years of age or older
Be taking Aricept (donepezil) 10 mg for at least 6 months
Not be taking Namenda (memantine)the last 2 months
Have a study partner able to attend study visits
Not participating in another clinical trial for at least 2 months
Qualified Participants May Receive:
Study medications and procedures at no cost
compensation for time and travel.